Menopause Care Is Primary Care, and the Traditional System Is Falling Short
There is a quiet crisis unfolding in the offices of primary care providers across the country. Women in their 40s and 50s are walking in with a constellation of symptoms: disrupted sleep, cognitive fog, mood changes, joint pain, worsening anxiety, declining libido, heart palpitations. Then, they are walking out with referrals, antidepressants, or simply the advice to push through. They leave without a real conversation about what is actually happening to their bodies, without a personalized plan, and without a provider who has the time to truly understand their history.
The problem is not that primary care providers don't care. The problem is that the traditional primary care model - constrained by time, shaped by insurance reimbursement, and organized around acute illness and putting out chronic disease fires - is structurally incapable of delivering what midlife women actually need.
Menopause care is primary care. It belongs at the center of a woman's health in midlife, not referred out, not rushed through in fifteen minutes, not reduced to a prescription for a hot flash or a pamphlet about calcium supplements. The perimenopausal and menopausal transition touches every organ system, intersects with every major chronic disease risk, and unfolds over years - sometimes decades. Caring for a woman through it well requires time, clinical depth, and a genuine relationship. That is exactly what direct primary care is built to provide - AND this is why I am currently researching how to implement quality improvement programs in primary care offices to improve the experience for all women in a variety of settings.
What Gets Lost in the Traditional Primary Care Visit
The average primary care appointment in the United States lasts between 15 and 18 minutes. In that time, a provider is expected to address the presenting concern, review medications, document everything required for insurance billing, and check boxes on whatever preventive care metrics are due (trust me, these things are flashing on the left hand side of the screen in insurance clinic settings - very annoying). In that context, there is no room for nuance. There is no room for a conversation that begins with "I haven't been feeling like myself for two years and I don't know how to describe it." (linked is the paper describing the phenomena of “Not Feeling Like Myself” and the 57 symptoms that entails!)
There are four areas in particular where the traditional primary care model consistently misses the mark in my experience for midlife women - and where the consequences of those gaps are measured in real health outcomes.
Gap One: Breast Cancer Screening Without Personalization
Most women in midlife receive their breast cancer screening guidance from a pamphlet or a checkbox. They're told to get a mammogram annually or every two years - the exact recommendation depending on which guideline their insurer follows = and that's where the conversation ends.
But breast cancer screening is not one-size-fits-all, and for midlife women, a personalized approach can be genuinely lifesaving.
Breast cancer risk varies enormously from woman to woman based on factors that a fifteen-minute primary care visit rarely captures in full: family history across multiple generations, personal history of biopsy findings such as atypical ductal hyperplasia or lobular carcinoma in situ, breast density on prior mammography, genetic mutations including BRCA1 and BRCA2, radiation exposure history, reproductive history including age at first period and first pregnancy. A woman at average risk and a woman with dense breasts, a first-degree relative with premenopausal breast cancer, and a prior biopsy showing atypical cells should not be on the same screening protocol - and yet in a busy traditional practice, they often are.
The questions that personalized breast cancer screening requires are not quick ones. They involve reviewing family history carefully and determining whether genetic testing is appropriate. They involve discussing what breast density actually means on a mammogram report, what supplemental screening tools like breast MRI or ultrasound are available, and when those are indicated. They involve calculating a formal lifetime risk using a validated tool - such as the Tyrer-Cuzick model or Gail Model - and using that number to guide decisions about screening frequency, modality, genetic testing, and referral for high-risk programs.
This is a conversation that takes twenty to thirty minutes to do well. In a direct primary care model like our clinic, it actually happens.
Gap Two: Cardiovascular Risk That Goes Uncalculated and Uncounseled
Heart disease is the leading cause of death in women, and yet women in midlife are dramatically undertreated for cardiovascular risk - often because the risk itself is never properly assessed or communicated.
The traditional primary care visit may check a fasting cholesterol panel and note that LDL is "acceptable" without calculating an actual cardiovascular risk score, checking other biomarkers such as lipoprotein A, apoprotein B, or high sensitivity CRP, discussing the implications of borderline results, or considering the factors that are unique to women's risk profiles. This is a consequential oversight, and the evidence base has evolved in ways that make it even more so.
The new PREVENT calculator, introduced by the American Heart Association in 2023 and formally adopted in the 2026 ACC/AHA Dyslipidemia Guidelines released just last month, represents the most significant overhaul of cardiovascular risk assessment in over a decade. Unlike the older Pooled Cohort Equations, PREVENT estimates both 10-year and 30-year cardiovascular risk beginning at age 30, incorporates kidney function, metabolic health, and social determinants of health, and provides sex-specific calculations without using race as a biological variable.
This matters for midlife women in a specific and urgent way. Many women in their 40s and early 50s will show a 10-year risk that appears reassuringly low - but a 30-year risk that is substantial. Without a provider who calculates both and explains what they mean, a woman walks away believing her heart is fine when in reality her trajectory needs to change now.
The 2026 dyslipidemia guidelines also restored specific LDL-C treatment targets - less than 100 mg/dL for borderline to intermediate risk and less than 70 mg/dL for high risk - and expanded the treatment toolkit significantly with PCSK9 inhibitors, bempedoic acid, inclisiran, and icosapent ethyl. But none of those tools reach a woman who was never told she needed them. These risks have to be calculated but also use “risk enhancers” such as pregnancy outcomes, family history, and advanced biomarkers mentioned.
Perhaps most critically for women, the 2026 guidelines and current cardiovascular prevention literature explicitly recognize female-specific cardiovascular risk enhancers that a standard risk calculator will miss entirely. A history of preeclampsia or gestational hypertension doubles a woman's lifetime ischemic heart disease risk. A history of gestational diabetes dramatically accelerates her risk of type 2 diabetes and cardiovascular disease. Premature menopause before age 45, polycystic ovary syndrome, autoimmune conditions like lupus or rheumatoid arthritis, and elevated lipoprotein a - which should be checked at least once in every adult's lifetime per the 2026 guidelines - all substantially modify cardiovascular risk in ways that a standard cholesterol panel will never reveal.
The conversation a midlife woman deserves about her cardiovascular health cannot happen in a fifteen-minute slot. It requires reviewing her full reproductive history, calculating her PREVENT risk score, checking Lp(a) if it hasn't been done, discussing her specific LDL-C goal and what it will take to get there, and talking through the lifestyle and pharmacologic options in a way that centers her values and her life. This is the work of a real clinical relationship - not a checkbox or a unimpressive metric on the lefthand side of the screen.
Gap Three: Menopause Symptoms Beyond the Hot Flash
When menopause does come up in a traditional primary care visit, the conversation tends to follow a script: hot flashes, night sweats, vaginal dryness. Hormone therapy - yes or no. Maybe a handout about the Women's Health Initiative (sh!tty misrepresentation of the data).
This script misses most of what is actually happening to women during the menopausal transition, and it leaves millions of women without recognition, validation, or treatment for symptoms that are genuinely disabling their daily lives.
The perimenopausal transition is a neurological event as much as a hormonal one. Estrogen receptors are distributed throughout the brain, and the dramatic fluctuations and eventual decline of estrogen during perimenopause affect every system those receptors govern. This is why the symptom picture of menopause is so much broader than hot flashes.
Sleep disruption is one of the most commonly reported and most debilitating menopausal symptoms. It is often treated with a generic recommendation to "practice good sleep hygiene" rather than understood as a direct hormonal consequence warranting targeted intervention.
Cognitive changes - difficulty concentrating, word-finding problems, memory lapses, the sense of "brain fog" that women describe with striking consistency - are among the most distressing symptoms of perimenopause, in part because they are frightening and in part because providers often dismiss them, attribute them to stress, or refer women for dementia workups when what they're experiencing is a well-documented neurological consequence of estrogen fluctuation.
Mood disturbances are prevalent during the perimenopausal transition in ways that go beyond typical life stress. Women with no prior history of depression or anxiety frequently develop both during perimenopause, driven in part by the same estrogen-related disruption of serotonin and dopamine signaling. These women often leave primary care visits with a prescription for an SSRI and no acknowledgment that what they're experiencing has a hormonal component that might be more precisely addressed.
Joint pain and musculoskeletal symptoms, affecting tendons, fascia, and joints in ways that seem unrelated to prior injury or arthritis, are reported by a majority of women during the menopausal transition and are rarely connected to perimenopause in a clinical conversation. This symptom is one of the most commonly seen ones in my practice, but yet one of the most underreported!
Palpitations, changes in urinary frequency and urgency, skin and hair changes, weight redistribution, and significant decreases in libido and sexual function round out a symptom picture that extends well beyond what the standard menopause screening question captures.
Caring well for menopausal symptoms requires a provider who understands the full spectrum, who has done the work (not an 8 hour CME course) to stay current on the evidence for and against hormone therapy beyond the misrepresented Women's Health Initiative headlines, who can have an individualized, nuanced conversation about the timing hypothesis, the risks and benefits for each patient based on her specific history, and the full menu of hormonal and non-hormonal options available - from FDA-approved hormone formulations to newer agents like Lynkuet and Duavee. It requires a provider who asks about libido and sexual health without embarrassment, who can address genitourinary syndrome of menopause comprehensively, and who treats a woman's quality of life as a legitimate clinical outcome.
That is not a fifteen-minute conversation. It is an ongoing relationship. The crux of a direct primary care clinic like ours.
Gap Four: Someone Who Actually Shows Up - Navigating the Healthcare System
The fourth gap is harder to quantify but perhaps the most profound. It is the absence of a provider who functions as a genuine navigator and advocate for a woman moving through a complex, fragmented healthcare system.
Midlife women are among the most medically active people in the healthcare system. They are navigating referrals to gynecology, cardiology, dermatology, neurology, gastroenterology, and mental health. They are receiving imaging reports and lab results that need interpretation. They are making decisions about hormone therapy with information that is frequently contradictory online, alarmist in the mainstream media, and from uninformed healthcare providers who may not have ill-intent. They are managing aging parents, taking care of their kids while advocating for their own health - I call this the caregiver sandwich. They are trying to understand what their mammogram report actually means, why their cardiologist wants to start a medication their primary care provider hasn't mentioned, and whether the fatigue, weight changes, and low mood they're experiencing are "normal aging" or something that can actually be treated.
In a traditional primary care model, the fifteen-minute appointment is not designed to address any of this. Referrals are generated but the follow-through often falls to the patient. Test results arrive through a portal without context. Specialists speak to each other inconsistently. The woman in the middle is left to piece it together herself. I created my practice for this very woman who falls through the cracks - she’s not acutely ill and she doesn’t need a chronic disease fire to be put out.
Direct primary care changes this fundamentally. Longer appointments, direct access to your provider, unhurried communication through phone, text, or email - these are not luxuries. For a woman in midlife navigating simultaneous decisions about cancer screening, cardiovascular risk, menopausal symptoms, and mental health, they are medical necessities. They are what allows a provider to actually know her patient: her history, her values, her fears, her goals. They are what allows real preventive care to happen - not just boxes checked, but a genuine plan built around the individual woman in front of you.
Why This Model Matters Now
We are in a moment when the evidence base for midlife women's health has never been richer. We have better cardiovascular risk tools than ever before. We have evolving, evidence-based guidance on hormone therapy that moves beyond the fear-based framing of twenty years ago. We have personalized approaches to cancer screening that can genuinely reduce mortality in high-risk women while avoiding overtreatment in lower-risk ones. We have a growing understanding of how the menopausal transition affects the brain, the heart, the bones, the immune system, and the psyche - and what can be done about it.
What we don't have, in the traditional healthcare model, is the time and structure to deliver any of this well. I will never forget when Dr. Andrew Weil gave a talk and he said, the center of integrative medicine is the relationship between provider and patient. Let’s not forget that sometimes the therapeutic benefit is having a trusted provider who understands the evidence but also understands your story.
That is how our practice operates, and how many practices operate who follow this model of care - one built around the idea that a midlife woman deserves a provider who knows her, has time for her, stays current on the evidence that pertains to her, and shows up for her not just in a crisis, but in the ongoing work of staying well.
Menopause care is primary care. And it's time for primary care to actually deliver it.
This article is intended for educational purposes and does not constitute medical advice. If you are interested in personalized, comprehensive midlife care, please reach out to learn more about our direct primary care practice.
